Nuclear Medicine and Biology
Volume 34, Issue 4 , Pages 425-432, May 2007

Cellular metabolic responses of PET radiotracers to 188Re radiation in an MCF7 cell line containing dominant-negative mutant p53

  • Gi Jeong Cheon

      Affiliations

    • Laboratory of Nuclear Medicine Research, Korea Institute of Radiological and Medical Sciences, Seoul 139-706, South Korea
    • Department of Nuclear Medicine, Korea Institute of Radiological and Medical Sciences, Seoul 139-706, South Korea
    • Corresponding Author InformationCorresponding author. Department of Nuclear Medicine, Korea Institute of Radiological and Medical Sciences, Nowon-Gu, Seoul 139-706, South Korea. Tel.: +82 2 970 1341; fax: +82 2 970 1341.
  • ,
  • Hye-Kyung Chung

      Affiliations

    • Laboratory of Nuclear Medicine Research, Korea Institute of Radiological and Medical Sciences, Seoul 139-706, South Korea
  • ,
  • Jung-A Choi

      Affiliations

    • Laboratory of Radiation Experimental Therapeutics, Korea Institute of Radiological and Medical Sciences, Seoul 139-706, South Korea
  • ,
  • Su-Jae Lee

      Affiliations

    • Laboratory of Radiation Experimental Therapeutics, Korea Institute of Radiological and Medical Sciences, Seoul 139-706, South Korea
  • ,
  • Soon-Hyuk Ahn

      Affiliations

    • Laboratory of Nuclear Medicine Research, Korea Institute of Radiological and Medical Sciences, Seoul 139-706, South Korea
  • ,
  • Tae-Sup Lee

      Affiliations

    • Laboratory of Nuclear Medicine Research, Korea Institute of Radiological and Medical Sciences, Seoul 139-706, South Korea
  • ,
  • Chang Woon Choi

      Affiliations

    • Department of Nuclear Medicine, Korea Institute of Radiological and Medical Sciences, Seoul 139-706, South Korea
  • ,
  • Sang Moo Lim

      Affiliations

    • Department of Nuclear Medicine, Korea Institute of Radiological and Medical Sciences, Seoul 139-706, South Korea

Received 14 September 2006; received in revised form 28 January 2007; accepted 29 January 2007. published online 02 April 2007.

Abstract 

We investigated the relations between the cell uptakes of metabolic radiotracers and β-radiation pretreatment using a dominant mutant p53 (p53mt) cell line to evaluate the effects of p53 genes on 18F labeled positron emission tomography (PET) radiotracer uptakes.

Methods

pCMV-Neo-Bam (control), which contains a neo-resistance marker, and p53 dominant-negative mutant expression constructs were stably transfected into MCF7 cell line. Cells were plated in 24-well plates at 1.0×105 cells for 18 h. Rhenium-188 (188Re) (a beta emitter) was added to the medium (3.7, 18.5, 37 MBq) and incubated for 24 h. We performed gamma-counting to determine the cellular uptakes of 2-[18F]fluoro-2-deoxy-d-glucose (FDG), o-(2-[18F]fluoroethyl)-l-tyrosine (FET) and 2′-[18F]fluoro-2′-deoxythymidine (FLT) (370 kBq, 60 min). Cell viabilities were determined by trypan blue staining and flow cytometry.

Results

p53mt cells showed 1.5–2-fold higher FDG uptake than wild-type p53 cells in basal condition, and the difference of FDG uptake was greater after 188Re treatment (P<.01). FET uptake increased with 188Re dose without a significant difference between p53 statuses. p53mt cells showed lower FLT uptake than wild-type p53 cells in basal condition, and the difference of FLT uptake was greater after 188Re treatment. By cell viability testing and FACS analysis, p53mt cells showed lower viability and a larger apoptotic fraction (sub-G1) than wild-type p53 cells after 188Re treatment.

Conclusion

We speculate that p53 dysfunction increases glucose and decreases thymidine metabolism in cancer cells and that this may be exaggerated by 188Re β-radiation. Our findings suggest that FDG could reflect tumor viability and malignant potential after 188Re β-radiation treatment, whereas FLT could be a more useful PET radiotracer for assessing therapeutic response to β-radiation, especially in cancer cells with an altered function of p53.

Keywords: 2-[18F]fluoro-2-deoxy-d-glucose, o-(2-[18F]fluoroethyl)-l-tyrosine, 2′-[18F]fluoro-2′-deoxythymidine, p53, β-radiation, Positron emission tomography

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This study was partly supported by Korea Science and Engineering Foundation and Ministry of Science & Technology, Republic of Korea, through its National Nuclear Technology Program.

PII: S0969-8051(07)00037-6

doi:10.1016/j.nucmedbio.2007.01.011

Nuclear Medicine and Biology
Volume 34, Issue 4 , Pages 425-432, May 2007